A randomized, double-blind, active-control trial to evaluate the efficacy and safety of a three day course of tafenoquine monotherapy for the treatment of Plasmodium vivax malaria.
Tafenoquine is an investigational 8-aminoquinoline for the prevention of Plasmodium vivax relapse. Tafenoquine has a long half-life and the potential for more convenient dosing, compared with the currently recommended 14-day primaquine regimen.This randomized, active-control, double-blind trial was...
Spremljeno u:
| Glavni autori: | , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Public Library of Science (PLoS)
2017-01-01
|
| Serija: | PLoS ONE |
| Online pristup: | http://europepmc.org/articles/PMC5679603?pdf=render |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|